Product Details

Oxmax (previously OC99) 65 mg/ml Solution for Infusion for Dogs

• MA holder: New Alpha Innovation Biopharmaceutical Ireland Limited
• VM number: EU/2/23/299/001
• Territory: Northern Ireland
• Associated documents:
  • Available from EU Union Product Database
• Date of issue: 14/11/2023
• Authorisation route: Centralised
• Active substances:
  • Hemoglobin betafumaril (bovine)
• Controlled drug: No
• Target species:
  • Dogs
• Distribution category: POM-V